← Leaderboards
Erxi Wu
Baylor Research Institute
$1,243,355
Attributed
$1,243,355
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $232.7K · FY2016–23$250K$187.5K$125K$62.5K$0
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,243,355 · 2
By mechanism
P20$840,258 · 1
R21$403,097 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Therapeutic Target”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$399,079,477
- Judith S. Currier · University Of California Los Angeles$274,271,371
- Peter C Adamson · National Childhood Cancer Foundation$268,343,924
- Barbara Driver · Westat, Inc.$175,154,472
Research focus
Therapeutic TargetSpecimenMouse ModelProteinsPublishingSalinomycinInsightMalignant NeoplasmsNucleolinPathway InteractionsPublic HealthAntineoplastic AgentsReportingResistanceClinically RelevantCell ProliferationIn VitroIn VivoCancer Stem CellCytotoxicityBindingDiagnosisBinding ProteinsTumor
Grant awards (6)
Salinomycin and its binding protein nucleolin in neuroblastoma$217,850
R21 · FY2023 · CA · contact PI
Salinomycin and its binding protein nucleolin in neuroblastoma$185,247
R21 · FY2022 · CA · contact PI
Effects of salinomycin and binding target proteins in pancreatic cancer$202,732
P20 · FY2019 · GM · contact PI
Effects of salinomycin and binding target proteins in pancreatic cancer$192,080
P20 · FY2018 · GM · contact PI
Effects of salinomycin and binding target proteins in pancreatic cancer$212,721
P20 · FY2017 · GM · contact PI
Effects of salinomycin and binding target proteins in pancreatic cancer$232,725
P20 · FY2016 · GM · contact PI